The plan calls for moving production of medical equipment "back to U.S. soil" and establishing stockpiles of certain products, in today's bite-sized hospital and health industry news from the District of Columbia and Illinois.
Hospitals throughout the United States are reporting shortages of remdesivir—the most promising experimental treatment for Covid-19 to date—as the number of new coronavirus cases in America continued to soar past the country's previous peak in its coronavirus epidemic.
A newly published study of more than 17 million people in England sheds light on how much a person's age, race/ethnicity, body mass index, and more are correlated with their risk of dying from Covid-19. See the patterns on our interactive chart.
Last week, Advisory Board's Ashley Fuoco Antonelli detailed her experience navigating her "suspected case of Covid-19." Now, she shares how the ordeal revealed three shortfalls threatening the country's ability to gain control of the new coronavirus' spread.
Organizations representing providers are once again reporting widespread shortages of protective gear—including respirator masks, gowns, and gloves—leading some health care workers to reuse or forgo equipment. Many fear the problem will only get worse as coronavirus cases continue to spike.
When Davon Hill, a generally healthy 24-year-old, developed Covid-19, his doctors thought he would recover—but, within 24 hours, the disease shut down his organs, and Hill succumbed to the new coronavirus, Jim Little reports for the Pensacola News Journal.